The HBeAg (Hepatitis B Envelope Antigen) Test detects the presence of the hepatitis B envelope antigen in the blood, which indicates active replication of the virus and a higher level of infectiousness. This test is essential for individuals diagnosed with hepatitis B to determine the stage of the infection and assess the risk of transmitting the virus to others. A positive HBeAg result often signifies active infection, suggesting that the virus is reproducing in the liver, which may require closer monitoring and possible medical intervention to manage liver health.

The HBeAg Test is critical for evaluating the level of hepatitis B viral activity, which helps determine the infection's contagiousness. Hepatitis B is a highly infectious virus that can lead to serious liver complications, such as cirrhosis and liver cancer, if untreated. Identifying the HBeAg status in hepatitis B-positive individuals supports early intervention, allowing healthcare providers to create an effective treatment plan and implement precautions to prevent virus transmission. Regular monitoring is especially vital for high-risk groups, such as healthcare workers and close family members of infected individuals.

Test price for other cities